CPHI’s Post

Biopharma is facing increasing pressure to consistently deliver new, innovative products to patients, gain a competitive advantage, and meet greater stakeholder expectations. We're exploring how organisations need to change the way they operate, at both an enterprise as well as partnership level, to fully realise the potential of strategic partnerships and maximise impact for patients. Later this month, we'll be attending Patients as Partners Europe and the NEXT conference in Dubrovnik, as well as sharing our insights on how pharma companies can strategically partner with other organisations, healthcare professionals and patients to leverage their strengths, share risks, and unlock innovation. Find out more: https://ow.ly/xTzz50RvRMX #biotech #biopharma #pharma #lifesciences #pharmaceuticals #biotechnology Kate Moss (nee Watkins) Samantha Sierwald Joshua Elliott Chris Maxted

Catch up on the latest Komodo news: Attending SCOPE Summit 2024 from February 11-14? Come see us at booth #1012 and learn how to increase trial execution strategies leveraging real-world data and out-of-the-box analytics: https://lnkd.in/eD3Vv3j3 What needs to happen for RWE to reach its fullest regulatory potential? We asked that question at a roundtable with industry leaders during our One Day Summit. Read the takeaways: https://lnkd.in/emKq4FT2 Komodo's Professional Services team is transforming workflows within Life Sciences organizations. Read more about our holistic approach to innovation: https://lnkd.in/eSPnNbbf #KomodoInsights #SCOPESummit #rwe #rwd #data #analytics #lifesciences #pharmaceutical #komodosummit #healthcare

Stephanie Gaulding, CQA, CPGP cites a shift in focus toward core competencies and the opportunity to leverage strengths from partners as beneficial in a high-risk environment. “One of the biggest benefits of risk-sharing in outsourcing operations centers on both organizations focusing on their core competencies and leveraging the strength of their partner,” she states. “This often means that drug sponsors have access to experts in processing technologies, laboratory methods, and other competencies that may not be resident in their own organization and similarly for the outsourcing organization, they can lean into the drug sponsor for expertise in the patient profile, including severity assessment and impact, for identified risks and mitigation strategies.” #usp #drugdevelopment #lifescienceindustry #drugdiscovery #cellandgenetherapy #smallmolecule #genericpharma #biologics To register for the full report: The 2024 Pharma Outsourcing Forecast: strategic partnerships across global landscapes (cphi-online.com)

Unlock the future of Pharma investment with insights from industry finance experts! 🌐📊 At CPHI Barcelona last October, we held a roundtable discussion where financial thought leaders explored the evolving landscape and changing investment strategies in the health and pharmaceutical sector. 💡 Download our comprehensive report now for a deep dive into these trends shaping the industry's future in Catalonia and globally: https://ow.ly/y4a850QsqJb #CPHIBCN #PharmaFinance #InvestmentTrends #CPHIBarcelona2023 #AtTheHeartOfPharma #PharmaInsights

Thoughts on this? >> #AAD24 roundup: Data from Sanofi, Alumis, Galderma and more >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #biotech #pharmaceutical

Uncovering Another Exciting Highlight from CPhI 2023! During this year's CPhI in Barcelona, Natalie Schwertheim from Packaging Insights (CNS Media Ltd) had the opportunity to interview Christoph Staub and delve deep into the unique pharmaceutical packaging solutions offered by #allpackgroupag. Two standout themes emerged as potential game-changers: 1. #allpackgroupag takes the lead in innovation by introducing PVC-free blister pack materials. This eco-conscious approach not only aligns with sustainability goals but also prioritizes the safety and well-being of patients. 2. Late-stage customization, an increasingly vital element of pharmaceutical packaging, is a key focus at #allpackgroupag. This personalized touch enhances efficiency and adaptability in packaging processes, catering to the ever-evolving needs of the pharmaceutical industry. Beyond these insights, Christoph Staub also shared his perspectives on the growing significance of brand protection and digital transformation within the pharmaceutical sector. As we set our sights on the future, these factors are poised to reshape the industry landscape. Stay tuned for more updates as we continue our journey to explore the latest trends and innovations in the pharmaceutical world. Let's work together to drive positive change and stay ahead of the curve! Here's the link to Natalie's interview with Christoph Staub: https://lnkd.in/e6uUV7DS #allpackgroupag #cphi2023 #pharmaceuticalpackaging #innovation #sustainability #brandprotection #digitaltransformation

This is a very important topic with industry leaders and influencers. Send me a message if you want more information. See you there! #DIA2024 #ICH #Data #RegulatoryOperations

Unlock the future of Pharma investment with insights from industry finance experts! 🌐📊 At CPHI Barcelona last October, we held a roundtable discussion where financial thought leaders explored the evolving landscape and changing investment strategies in the health and pharmaceutical sector. 💡 Download our comprehensive report now for a deep dive into these trends shaping the industry's future in Catalonia and globally: https://ow.ly/y4a850QsqJb #CPHIBCN #PharmaFinance #InvestmentTrends #CPHIBarcelona2023 #AtTheHeartOfPharma #PharmaInsights

It was a pleasure to be able to attend this roundtable at CPHI Barcelona last year, set up by Sophie W. (👏), and be a fly on the wall for an insightful discussion on investing and the Start-Up and biotech space in Catalonia. It was a great opportunity for me to learn about funding and the crucial financial side of things in pharma as well as some of the technology trends our experts highlighted. 📈 The report goes into depth on both sides of the investing coin as it were, from the perspective of venture capitals and seed companies, with some illuminating observations from key experts - make sure to download your copy below! ⬇ #biotech #investing #business

Today’s newly launched annual #100DM report acts as a ‘pulse check’ on how close the world is to achieving the 100DM and the most critical priorities for collective action. It offers a roadmap toward a more resilient, equitable, and responsive product development landscape. It’s becoming increasingly clear that we need to ensure that science and innovation remain front and center of our plans. Pharmaceutical companies have backed the ambition of the #100DM since it was set out in 2021. But global leaders need to urgently refocus on practical steps, preserving the innovation ecosystem, while addressing the inequitable roll-out that we have seen during the COVID-19 pandemic. Read the report: https://lnkd.in/e5agPZKb   International Pandemic Preparedness Secretariat | Thomas Cueni